Javascript must be enabled to continue!
Plasmid-based CRISPR-Cas9 gene editing in multiple Candida species
View through CrossRef
ABSTRACT
Many
Candida
species that cause infection have diploid genomes, and do not undergo classical meiosis. The application of CRISPR-Cas9 gene editing systems have therefore greatly facilitated the generation of gene disruptions, and the introduction of specific polymorphisms. However, CRISPR methods are not yet available for all
Candida
species. We describe here an adaption of a previously developed CRISPR system in
Candida parapsilosis
that uses an autonomously replicating plasmid. Guide RNAs can be introduced in a single cloning step, and are released by cleavage between a tRNA and a ribozyme. The plasmid also contains
CAS9
and a selectable nourseothricin
SAT1
marker. It can be used for markerless editing in
C. parapsilosis, C. orthopsilosis
and
C. metapsilosis
. We also show that CRISPR can easily be used to introduce molecular barcodes, and to reintroduce wild type sequences into edited strains. Heterozygous mutations can be generated, either by careful selection of the distance between the polymorphism and the Cas9 cut site, or by providing two different repair templates at the same time. In addition, we have constructed a different autonomously replicating plasmid for CRISPR-Cas9 editing in
Candida tropicalis
. We show that editing can easily be carried out in multiple
C. tropicalis
isolates. NHEJ repair occurs at a high level in
C. metapsilosis
and
C. tropicalis
.
IMPORTANCE
Candida
species are a major cause of infection worldwide. The species associated with infection vary with geographical location, and patient population. Infection with
Candida tropicalis
is particularly common in South America and Asia, and
Candida parapsilosis
infections are more common in the very young. Molecular methods for manipulating the genomes of these species are still lacking. We describe a simple and efficient CRISPR-based gene editing system that can be applied in the
C. parapsilosis
species group, including the sister species
Candida orthopsilosis
and
Candida metapsilosis
. We have also constructed a separate system for gene editing in
C. tropicalis
.
Title: Plasmid-based CRISPR-Cas9 gene editing in multiple
Candida
species
Description:
ABSTRACT
Many
Candida
species that cause infection have diploid genomes, and do not undergo classical meiosis.
The application of CRISPR-Cas9 gene editing systems have therefore greatly facilitated the generation of gene disruptions, and the introduction of specific polymorphisms.
However, CRISPR methods are not yet available for all
Candida
species.
We describe here an adaption of a previously developed CRISPR system in
Candida parapsilosis
that uses an autonomously replicating plasmid.
Guide RNAs can be introduced in a single cloning step, and are released by cleavage between a tRNA and a ribozyme.
The plasmid also contains
CAS9
and a selectable nourseothricin
SAT1
marker.
It can be used for markerless editing in
C.
parapsilosis, C.
orthopsilosis
and
C.
metapsilosis
.
We also show that CRISPR can easily be used to introduce molecular barcodes, and to reintroduce wild type sequences into edited strains.
Heterozygous mutations can be generated, either by careful selection of the distance between the polymorphism and the Cas9 cut site, or by providing two different repair templates at the same time.
In addition, we have constructed a different autonomously replicating plasmid for CRISPR-Cas9 editing in
Candida tropicalis
.
We show that editing can easily be carried out in multiple
C.
tropicalis
isolates.
NHEJ repair occurs at a high level in
C.
metapsilosis
and
C.
tropicalis
.
IMPORTANCE
Candida
species are a major cause of infection worldwide.
The species associated with infection vary with geographical location, and patient population.
Infection with
Candida tropicalis
is particularly common in South America and Asia, and
Candida parapsilosis
infections are more common in the very young.
Molecular methods for manipulating the genomes of these species are still lacking.
We describe a simple and efficient CRISPR-based gene editing system that can be applied in the
C.
parapsilosis
species group, including the sister species
Candida orthopsilosis
and
Candida metapsilosis
.
We have also constructed a separate system for gene editing in
C.
tropicalis
.
Related Results
Introduction to CRISPR/Cas9
Introduction to CRISPR/Cas9
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Genome engineering using CRISPR
Genome engineering using CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
BACKGROUND
Prokaryotes have evolved multiple systems to combat invaders such as viruses and plasmids. Examples of such defense systems include receptor masking,...
ets for CRISPR/Cas9-mediated gene drive in Bemisia tabaci
ets for CRISPR/Cas9-mediated gene drive in Bemisia tabaci
The goal of our BARD proposal was to build both the necessary infrastructure and knowledge for using the CRISPR/Cas9-based gene drive system to control the whitefly Bemisia tabaci....
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Since its inception in 2012, the gene editing technology CRISPR-Cas9 has rapidly become a revolutionary tool in the field of gene editing due to its high efficiency, specificity, a...
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
Background: CRISPR/Cas9 genome-editing technology has revolutionized human stem cell (HSC) research, offering novel therapeutic and diagnostic applications. HSCs play a crucial rol...
Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms
Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms
The interactions between pathogens during infection and the impact of these interactions on drug effectiveness are poorly understood, making polymicrobial infections challenging to...
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
The revolutionary potential of CRISPR-Cas9 in medicine lies in its unparalleled precision in gene editing, heralding a new era for treating genetic disorders. This study focuses on...

